nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—LRP12—glaucoma	0.0891	0.293	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—LRP12—glaucoma	0.0455	0.149	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—ABCA1—glaucoma	0.0195	0.064	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Retinoid metabolism and transport—APOE—glaucoma	0.015	0.0494	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—APOE—glaucoma	0.0128	0.0421	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Lipid and lipoprotein metabolism—CAV1—glaucoma	0.0127	0.0417	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal discomfort—Carbachol—glaucoma	0.0113	0.0163	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Physostigmine—glaucoma	0.0101	0.0145	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Physostigmine—glaucoma	0.00941	0.0135	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal discomfort—Apraclonidine—glaucoma	0.00828	0.0119	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Carbachol—glaucoma	0.00813	0.0117	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Diseases associated with visual transduction—APOE—glaucoma	0.00767	0.0252	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain upper—Brinzolamide—glaucoma	0.00736	0.0106	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.00678	0.0223	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal discomfort—Brinzolamide—glaucoma	0.00668	0.0096	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NARFL—glaucoma	0.00638	0.021	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CA5A—glaucoma	0.00638	0.021	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Diclofenamide—glaucoma	0.00607	0.00873	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Latanoprost—glaucoma	0.00603	0.00867	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Diclofenamide—glaucoma	0.00599	0.00862	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Diclofenamide—glaucoma	0.00595	0.00856	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Diclofenamide—glaucoma	0.00595	0.00855	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Carbachol—glaucoma	0.00592	0.00852	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—LRP12—glaucoma	0.00577	0.019	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain upper—Clonidine—glaucoma	0.00565	0.00812	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Methazolamide—glaucoma	0.00559	0.00804	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Methazolamide—glaucoma	0.00552	0.00794	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Methazolamide—glaucoma	0.00548	0.00788	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Methazolamide—glaucoma	0.00547	0.00787	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Metipranolol—glaucoma	0.00543	0.00781	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Carbachol—glaucoma	0.00532	0.00765	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Carteolol—glaucoma	0.00503	0.00724	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Metipranolol—glaucoma	0.00501	0.0072	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Diclofenamide—glaucoma	0.00495	0.00711	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Brinzolamide—glaucoma	0.00485	0.00698	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Apraclonidine—glaucoma	0.00482	0.00693	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Brinzolamide—glaucoma	0.00478	0.00687	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Metipranolol—glaucoma	0.00477	0.00686	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Metipranolol—glaucoma	0.00477	0.00686	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Levobunolol—glaucoma	0.00476	0.00684	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Metipranolol—glaucoma	0.00474	0.00682	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Bimatoprost—glaucoma	0.00467	0.00672	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Carteolol—glaucoma	0.00464	0.00667	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Carbachol—glaucoma	0.00461	0.00662	CcSEcCtD
Glycerol Phenylbutyrate—Flatulence—Pilocarpine—glaucoma	0.0046	0.00661	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Diclofenamide—glaucoma	0.00456	0.00656	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Methazolamide—glaucoma	0.00456	0.00655	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Levobunolol—glaucoma	0.00453	0.00652	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Metipranolol—glaucoma	0.0045	0.00647	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Carbachol—glaucoma	0.00445	0.0064	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Carteolol—glaucoma	0.00439	0.00632	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Diclofenamide—glaucoma	0.00438	0.0063	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Levobunolol—glaucoma	0.00438	0.0063	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Diclofenamide—glaucoma	0.00435	0.00625	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Methazolamide—glaucoma	0.00434	0.00625	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Diclofenamide—glaucoma	0.00432	0.00621	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Carbachol—glaucoma	0.00428	0.00615	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Carbachol—glaucoma	0.00424	0.0061	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Apraclonidine—glaucoma	0.00424	0.0061	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Carbachol—glaucoma	0.00424	0.0061	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Apraclonidine—glaucoma	0.00424	0.00609	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Carbachol—glaucoma	0.00422	0.00606	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Bimatoprost—glaucoma	0.00419	0.00603	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Carteolol—glaucoma	0.00417	0.00599	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Levobunolol—glaucoma	0.00415	0.00597	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Brimonidine—glaucoma	0.00414	0.00595	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Bimatoprost—glaucoma	0.00411	0.00591	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Diclofenamide—glaucoma	0.0041	0.00589	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Latanoprost—glaucoma	0.00406	0.00584	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—LRP12—glaucoma	0.00404	0.0133	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Methazolamide—glaucoma	0.00404	0.0058	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Apraclonidine—glaucoma	0.00402	0.00578	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain upper—Timolol—glaucoma	0.00402	0.00578	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Methazolamide—glaucoma	0.004	0.00576	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Methazolamide—glaucoma	0.004	0.00575	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Carbachol—glaucoma	0.004	0.00575	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Methazolamide—glaucoma	0.00398	0.00572	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Levobunolol—glaucoma	0.00394	0.00566	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Travoprost—glaucoma	0.00393	0.00566	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Apraclonidine—glaucoma	0.00388	0.00558	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Brinzolamide—glaucoma	0.00388	0.00558	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Latanoprost—glaucoma	0.00388	0.00557	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Latanoprost—glaucoma	0.00387	0.00557	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Acetazolamide—glaucoma	0.00387	0.00556	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Latanoprost—glaucoma	0.00385	0.00554	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Acetazolamide—glaucoma	0.00382	0.00549	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00379	0.00546	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Acetazolamide—glaucoma	0.00379	0.00545	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Methazolamide—glaucoma	0.00377	0.00542	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—HEYL—glaucoma	0.00372	0.0122	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—FGFR1OP—glaucoma	0.00372	0.0122	CbGpPWpGaD
Glycerol Phenylbutyrate—Dyspepsia—Brimonidine—glaucoma	0.00371	0.00534	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Brimonidine—glaucoma	0.00364	0.00524	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Brimonidine—glaucoma	0.00364	0.00523	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Dorzolamide—glaucoma	0.00355	0.0051	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Travoprost—glaucoma	0.00353	0.00508	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Apraclonidine—glaucoma	0.00353	0.00507	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Dorzolamide—glaucoma	0.0035	0.00503	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Brinzolamide—glaucoma	0.00349	0.00501	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Dorzolamide—glaucoma	0.00347	0.00499	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Travoprost—glaucoma	0.00346	0.00498	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Travoprost—glaucoma	0.00346	0.00497	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Brinzolamide—glaucoma	0.00344	0.00495	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Brinzolamide—glaucoma	0.00342	0.00492	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Bimatoprost—glaucoma	0.00342	0.00491	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Brinzolamide—glaucoma	0.00341	0.00491	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Apraclonidine—glaucoma	0.00336	0.00483	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Pilocarpine—glaucoma	0.00335	0.00482	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Pilocarpine—glaucoma	0.00331	0.00476	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Dorzolamide—glaucoma	0.00329	0.00474	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00329	0.00472	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Travoprost—glaucoma	0.00328	0.00472	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Apraclonidine—glaucoma	0.00325	0.00467	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Betaxolol—glaucoma	0.00324	0.00466	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Dorzolamide—glaucoma	0.00318	0.00458	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Travoprost—glaucoma	0.00317	0.00456	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Acetazolamide—glaucoma	0.00315	0.00453	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Bimatoprost—glaucoma	0.00315	0.00453	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Apraclonidine—glaucoma	0.00312	0.00449	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CA1—glaucoma	0.00312	0.0102	CbGpPWpGaD
Glycerol Phenylbutyrate—Gastrointestinal pain—Pilocarpine—glaucoma	0.00311	0.00448	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Apraclonidine—glaucoma	0.0031	0.00445	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Apraclonidine—glaucoma	0.00308	0.00443	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Brimonidine—glaucoma	0.00303	0.00435	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CTSA—glaucoma	0.00302	0.00992	CbGpPWpGaD
Glycerol Phenylbutyrate—Abdominal pain—Pilocarpine—glaucoma	0.00301	0.00433	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Acetazolamide—glaucoma	0.00301	0.00432	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Bimatoprost—glaucoma	0.003	0.00432	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Bimatoprost—glaucoma	0.003	0.00431	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Bimatoprost—glaucoma	0.00298	0.00429	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Clonidine—glaucoma	0.00298	0.00429	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Apraclonidine—glaucoma	0.00292	0.0042	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Acetazolamide—glaucoma	0.00291	0.00418	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Dorzolamide—glaucoma	0.00289	0.00416	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Travoprost—glaucoma	0.00288	0.00414	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CA2—glaucoma	0.00285	0.00936	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Brinzolamide—glaucoma	0.00284	0.00409	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Bimatoprost—glaucoma	0.00283	0.00407	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—OPN4—glaucoma	0.0028	0.00921	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Acetazolamide—glaucoma	0.00279	0.00402	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Brimonidine—glaucoma	0.00279	0.00401	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.00279	0.00915	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.00279	0.00915	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Dorzolamide—glaucoma	0.00276	0.00396	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Acetazolamide—glaucoma	0.00275	0.00396	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Travoprost—glaucoma	0.00274	0.00395	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Pilocarpine—glaucoma	0.00273	0.00393	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Brinzolamide—glaucoma	0.00271	0.0039	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Dorzolamide—glaucoma	0.00266	0.00383	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Brimonidine—glaucoma	0.00266	0.00382	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Brimonidine—glaucoma	0.00266	0.00382	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Travoprost—glaucoma	0.00265	0.00381	CcSEcCtD
Glycerol Phenylbutyrate—Malnutrition—Timolol—glaucoma	0.00265	0.00381	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Brimonidine—glaucoma	0.00264	0.0038	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Clonidine—glaucoma	0.00264	0.0038	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Clonidine—glaucoma	0.00262	0.00377	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Clonidine—glaucoma	0.00262	0.00377	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Brinzolamide—glaucoma	0.00262	0.00377	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Acetazolamide—glaucoma	0.00261	0.00375	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HEYL—glaucoma	0.00261	0.00856	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Pilocarpine—glaucoma	0.0026	0.00374	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Betaxolol—glaucoma	0.0026	0.00373	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Dorzolamide—glaucoma	0.00256	0.00368	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Dorzolamide—glaucoma	0.00254	0.00365	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Dorzolamide—glaucoma	0.00254	0.00365	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Travoprost—glaucoma	0.00253	0.00364	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Travoprost—glaucoma	0.00253	0.00363	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Dorzolamide—glaucoma	0.00252	0.00363	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—PTGFR—glaucoma	0.00252	0.00829	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Brinzolamide—glaucoma	0.00252	0.00362	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Pilocarpine—glaucoma	0.00252	0.00362	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Travoprost—glaucoma	0.00251	0.00361	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Brimonidine—glaucoma	0.00251	0.0036	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Brinzolamide—glaucoma	0.0025	0.00359	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Brinzolamide—glaucoma	0.0025	0.00359	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Clonidine—glaucoma	0.00249	0.00357	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Brinzolamide—glaucoma	0.00248	0.00357	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Pilocarpine—glaucoma	0.00242	0.00348	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Clonidine—glaucoma	0.0024	0.00345	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Pilocarpine—glaucoma	0.0024	0.00345	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Pilocarpine—glaucoma	0.0024	0.00345	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Dorzolamide—glaucoma	0.00239	0.00344	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Pilocarpine—glaucoma	0.00238	0.00343	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Travoprost—glaucoma	0.00238	0.00343	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Brinzolamide—glaucoma	0.00235	0.00338	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Betaxolol—glaucoma	0.00233	0.00335	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Disease—HDAC9—glaucoma	0.00232	0.00763	CbGpPWpGaD
Glycerol Phenylbutyrate—Decreased appetite—Betaxolol—glaucoma	0.0023	0.00331	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Betaxolol—glaucoma	0.00228	0.00328	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Betaxolol—glaucoma	0.00228	0.00328	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Pilocarpine—glaucoma	0.00226	0.00325	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Clonidine—glaucoma	0.00218	0.00314	CcSEcCtD
Glycerol Phenylbutyrate—Nervous system disorder—Timolol—glaucoma	0.00212	0.00305	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Clonidine—glaucoma	0.00208	0.00299	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Clonidine—glaucoma	0.00201	0.00289	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—TXN—glaucoma	0.00201	0.0066	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—RPTOR—glaucoma	0.00197	0.00649	CbGpPWpGaD
Glycerol Phenylbutyrate—Vomiting—Clonidine—glaucoma	0.00193	0.00278	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Clonidine—glaucoma	0.00192	0.00276	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Clonidine—glaucoma	0.00192	0.00275	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NCK2—glaucoma	0.00191	0.00628	CbGpPWpGaD
Glycerol Phenylbutyrate—Headache—Clonidine—glaucoma	0.0019	0.00274	CcSEcCtD
Glycerol Phenylbutyrate—Dyspepsia—Timolol—glaucoma	0.0019	0.00274	CcSEcCtD
Glycerol Phenylbutyrate—Asthenia—Betaxolol—glaucoma	0.0019	0.00273	CcSEcCtD
Glycerol Phenylbutyrate—Decreased appetite—Timolol—glaucoma	0.00188	0.0027	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal disorder—Timolol—glaucoma	0.00187	0.00268	CcSEcCtD
Glycerol Phenylbutyrate—Fatigue—Timolol—glaucoma	0.00186	0.00268	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.00183	0.00602	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.00182	0.00596	CbGpPWpGaD
Glycerol Phenylbutyrate—Diarrhoea—Betaxolol—glaucoma	0.00181	0.0026	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Clonidine—glaucoma	0.00181	0.0026	CcSEcCtD
Glycerol Phenylbutyrate—Gastrointestinal pain—Timolol—glaucoma	0.00177	0.00254	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Betaxolol—glaucoma	0.00175	0.00252	CcSEcCtD
Glycerol Phenylbutyrate—Abdominal pain—Timolol—glaucoma	0.00171	0.00246	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Betaxolol—glaucoma	0.00168	0.00242	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Betaxolol—glaucoma	0.00167	0.0024	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Betaxolol—glaucoma	0.00167	0.0024	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Betaxolol—glaucoma	0.00166	0.00238	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—HDAC9—glaucoma	0.00163	0.00534	CbGpPWpGaD
Glycerol Phenylbutyrate—Nausea—Betaxolol—glaucoma	0.00157	0.00226	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTT1—glaucoma	0.00156	0.00512	CbGpPWpGaD
Glycerol Phenylbutyrate—Asthenia—Timolol—glaucoma	0.00155	0.00223	CcSEcCtD
Glycerol Phenylbutyrate—Diarrhoea—Timolol—glaucoma	0.00148	0.00213	CcSEcCtD
Glycerol Phenylbutyrate—Dizziness—Timolol—glaucoma	0.00143	0.00206	CcSEcCtD
Glycerol Phenylbutyrate—Vomiting—Timolol—glaucoma	0.00137	0.00198	CcSEcCtD
Glycerol Phenylbutyrate—Rash—Timolol—glaucoma	0.00136	0.00196	CcSEcCtD
Glycerol Phenylbutyrate—Dermatitis—Timolol—glaucoma	0.00136	0.00196	CcSEcCtD
Glycerol Phenylbutyrate—Headache—Timolol—glaucoma	0.00135	0.00195	CcSEcCtD
Glycerol Phenylbutyrate—Nausea—Timolol—glaucoma	0.00128	0.00185	CcSEcCtD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—SMO—glaucoma	0.00127	0.00418	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.00126	0.00412	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CDKN2B—glaucoma	0.00125	0.0041	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CYP1B1—glaucoma	0.00124	0.00408	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—ABCA1—glaucoma	0.00124	0.00408	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NTRK2—glaucoma	0.00116	0.00382	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—MTHFR—glaucoma	0.00105	0.00344	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NGFR—glaucoma	0.000999	0.00328	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—GSTM1—glaucoma	0.000992	0.00326	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—APOE—glaucoma	0.000974	0.0032	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CAV1—glaucoma	0.000965	0.00317	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NTRK1—glaucoma	0.000949	0.00312	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—BAD—glaucoma	0.000908	0.00298	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—MTHFR—glaucoma	0.000877	0.00288	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CDKN2B—glaucoma	0.000874	0.00287	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—EDN1—glaucoma	0.000839	0.00276	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—APOE—glaucoma	0.000816	0.00268	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—CAV1—glaucoma	0.000809	0.00266	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NGF—glaucoma	0.000771	0.00253	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—C3—glaucoma	0.000733	0.00241	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—NOS3—glaucoma	0.00073	0.0024	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—APOE—glaucoma	0.000682	0.00224	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CAV1—glaucoma	0.000676	0.00222	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—PTGS2—glaucoma	0.000668	0.00219	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—FN1—glaucoma	0.000643	0.00211	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—BAD—glaucoma	0.000636	0.00209	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Disease—CDKN1B—glaucoma	0.000632	0.00208	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—NOS3—glaucoma	0.000611	0.00201	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Metabolism—PTGS2—glaucoma	0.000559	0.00184	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—NOS3—glaucoma	0.000511	0.00168	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—CDKN1B—glaucoma	0.000443	0.00145	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—MMP9—glaucoma	0.00041	0.00135	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—VEGFA—glaucoma	0.000368	0.00121	CbGpPWpGaD
Glycerol Phenylbutyrate—PNLIP—Signaling Pathways—TP53—glaucoma	0.000278	0.000914	CbGpPWpGaD
